Physician profile
Eddie Davis
NPI 1609075902
$20,963.05
in general payments reported to CMS, 2019-2025
38 companies · $4,541 in 2025
The $4,541 reported for 2025 was more than what 93% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,965 · 2020: $329 · 2021: $7,416 · 2022: $529 · 2023: $4,172 · 2024: $1,012 · 2025: $4,541.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $6,000 · Food and Beverage: $3,714 · Travel and Lodging: $10.32.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $6,000.00 |
| Food and Beverage | $3,714.40 |
| Travel and Lodging | $10.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo Pharmaceuticals INC. | $8,676.81 | 2021-2023 | |
| Stryker Corporation | $5,031.06 | 2019-2025 | Augment Injectable, N/A, Asnis |
| Endo USA, INC. | $2,920.13 | 2024-2025 | |
| Medinc of Texas | $1,259.56 | 2021-2022 | |
| Smith+Nephew, INC. | $470.25 | 2019-2025 | Na, Grafix Pl, Bone Anchors With Arthroscopic Delivery System |
| Paratek Pharmaceuticals, INC. | $351.13 | 2020-2025 | Nuzyra |
| Amgen INC. | $273.84 | 2024-2025 | Krystexxa |
| Treace Medical Concepts, INC. | $185.38 | 2022-2025 | |
| Averitas Pharma INC. | $180.87 | 2024-2025 | Qutenza |
| Orthofix Medical, INC. | $158.40 | 2019-2025 | Physio-Stim |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $145.32 | 2021-2023 | Jublia |
| Janssen Pharmaceuticals, INC | $133.78 | 2021 | |
| Organogenesis INC. | $124.98 | 2023 | Affinity |
| Abbvie INC. | $115.45 | 2024-2025 | |
| Merck Sharp & Dohme LLC | $113.18 | 2019 |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $111.09 | 2019-2025 | Exparel |
| Kerecis Limited | $65.92 | 2020-2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Next Science LLC | $58.98 | 2023 | Xperience, Blastx, Surgx |
| Vertex Pharmaceuticals Incorporated | $58.56 | 2025 | |
| Nevro Corp. | $52.18 | 2022-2023 | Senza |
| Horizon Therapeutics Plc | $51.03 | 2019-2023 | Krystexxa |
| Mimedx Group, INC. | $48.00 | 2025 | |
| Mission Medical Distribution, LLC | $41.95 | 2024 | |
| Ossio INC | $41.14 | 2021 | |
| Convatec INC. | $38.89 | 2024 | |
| Integra Lifesciences Corporation | $35.01 | 2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Abbott Laboratories | $34.69 | 2022-2023 | Proclaim |
| Ibsa Pharma INC. | $21.42 | 2024 | Flector, Licart, Tirosint |
| Novastep INC. | $19.11 | 2022 | |
| Stimwave Technologies Incorporated | $18.81 | 2019 | |
| Solventum Corporation | $18.03 | 2025 | Promogran Prisma, Activ.A.C., V.A.C. Granufoam |
| Lifenet Health | $18.02 | 2023 | |
| Melinta Therapeutics, LLC | $17.99 | 2022 | |
| Sebela Pharmaceuticals INC. | $17.28 | 2019 | |
| Ani Pharmaceuticals, INC. | $16.03 | 2025 | Purified Cortrophin Gel |
| Medtronic, INC. | $13.71 | 2022 | |
| Bioventus LLC | $13.60 | 2019 | |
| Reprise Biomedical, INC. | $11.47 | 2024 | Miro3d |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eddie Davis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.